Narayana Hrudayalaya Ltd

Narayana Hrudaya Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Narayana Hrudayalaya Ltd

₹ 1,903 -0.85%
05 Aug - close price
narayanahealth.org BSE: 539551 NSE: NH
About

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Key Points

Hospital Portfolio[1]
- India: 18 owned/operated hospitals, 2 heart centers, 20 clinics and dialysis centers. Jammu unit is removed and is considered as a part of discontinued operation effective FY25.
- Cayman Islands: 2 hospital.
** - Total:** 42 healthcare facilities with 5,554 operational beds (including Cayman).

Website BSE NSE
  • Market Cap ₹ 38,895 Cr.
  • Current Price ₹ 1,903
  • High / Low ₹ 2,094 / 1,564
  • Stock P/E 66.3
  • Book Value ₹ 127
  • Dividend Yield 0.24 %
  • ROCE 19.8 %
  • ROE 22.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 55.9% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 19.6%

Cons

  • Stock is trading at 15.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty Smallcap 100 Nifty Smallcap250 Momentum Quality 100 Nifty MidSmallcap 400 BSE SmallCap Select Index BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
797 852 771 846 872 934 865 919 943 1,019 969 1,044 1,097
659 688 633 690 715 752 708 743 764 790 764 817 858
Operating Profit 138 164 138 156 157 183 157 176 179 229 205 227 239
OPM % 17% 19% 18% 18% 18% 20% 18% 19% 19% 22% 21% 22% 22%
9 14 11 89 14 13 9 107 16 17 -29 127 30
Interest 13 13 13 14 20 20 21 26 31 29 29 39 34
Depreciation 38 39 41 44 39 42 43 46 48 46 47 51 48
Profit before tax 96 126 95 187 110 134 101 211 117 171 99 264 188
Tax % 18% 13% 17% 15% 22% 21% 22% 24% 26% 20% 24% 23% 27%
79 109 79 158 86 106 79 160 87 138 76 202 138
EPS in Rs 3.86 5.33 3.85 7.74 4.23 5.16 3.88 7.83 4.28 6.75 3.71 9.89 6.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
1,308 1,470 1,646 1,848 2,077 2,239 1,655 2,412 2,965 3,266 3,590 3,975 4,129
1,182 1,295 1,427 1,664 1,881 1,971 1,676 2,146 2,471 2,656 2,905 3,117 3,230
Operating Profit 126 175 219 184 196 268 -21 266 494 609 685 859 900
OPM % 10% 12% 13% 10% 9% 12% -1.3% 11% 17% 19% 19% 22% 22%
10 2 14 16 17 19 71 104 95 120 139 124 145
Interest 38 23 17 26 43 55 48 45 55 65 98 139 130
Depreciation 64 67 68 78 91 128 123 119 139 161 169 191 192
Profit before tax 34 86 147 95 79 104 -121 206 395 503 557 652 722
Tax % 38% 34% 35% 39% 37% 35% -35% 35% 33% 16% 23% 23%
21 57 95 58 50 68 -79 134 266 425 431 503 554
EPS in Rs 1.05 2.77 4.65 2.86 2.45 3.31 -3.85 6.54 13.00 20.77 21.10 24.62 27.10
Dividend Payout % 0% 0% 0% 0% 41% 30% 0% 15% 19% 19% 21% 18%
Compounded Sales Growth
10 Years: 10%
5 Years: 19%
3 Years: 10%
TTM: 13%
Compounded Profit Growth
10 Years: 24%
5 Years: 56%
3 Years: 27%
TTM: 36%
Stock Price CAGR
10 Years: 20%
5 Years: 29%
3 Years: 23%
1 Year: 5%
Return on Equity
10 Years: 14%
5 Years: 21%
3 Years: 23%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 200 204 204 204 204 204 204 204 204 204 204 204
Reserves 595 753 854 916 963 962 885 1,021 1,264 1,636 1,981 2,393
289 152 120 491 499 607 551 533 644 1,011 1,595 1,970
216 274 309 383 410 449 462 528 664 645 722 860
Total Liabilities 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 4,502 5,427
651 650 682 973 949 1,159 1,070 1,094 1,358 1,480 2,325 2,434
CWIP 9 13 52 30 56 3 5 23 32 34 43 234
Investments 241 334 354 561 597 619 645 661 678 1,021 1,166 1,087
399 386 399 431 475 441 382 507 709 962 967 1,672
Total Assets 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 4,502 5,427

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
61 177 218 196 208 286 123 246 516 542 523 759
-192 -130 -162 -446 -137 -129 -12 -117 -621 -761 -755 -960
127 -2 -32 226 -11 -170 -114 -57 65 237 391 134
Net Cash Flow -4 46 25 -24 61 -12 -3 72 -40 19 159 -68
Free Cash Flow -18 112 93 7 105 194 88 66 272 40 -181 242
CFO/OP 64% 120% 116% 123% 131% 128% -349% 113% 120% 101% 91% 107%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 40 34 31 37 28 24 34 26 22 21 25 30
Inventory Days 55 46 42 41 36 24 19 18 17 28 20 17
Days Payable 136 142 161 179 165 171 237 177 211 192 168 175
Cash Conversion Cycle -41 -62 -88 -102 -101 -124 -184 -133 -172 -143 -122 -128
Working Capital Days -20 -6 -2 -10 -15 -26 -53 -36 -40 -39 -33 -24
ROCE % 7% 11% 15% 9% 8% 9% -4% 15% 23% 23% 19% 20%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cayman Hospital Revenues (HCCI + EICL)
USD Mn

Log in to view insights

Please log in to see hidden values.

Login
ALOS (Average Length of Stay) - India Hospitals
days
ARPOB (Average Revenue Per Operational Bed) - India Hospitals
INR Mn per quarter
IP Footfalls (Discharges) - India Hospitals
thousands
Operational Beds (Group)
count
OP Footfalls (Out-Patients) - India Hospitals
thousands
Cayman Insurance Revenues (CIHL Gross Written Premium)
USD Mn

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.27% 63.27% 63.27%
11.59% 11.51% 10.91% 10.01% 9.69% 9.45% 9.66% 10.46% 10.49% 11.10% 9.98% 9.40%
10.89% 10.23% 9.51% 8.22% 7.90% 8.68% 8.52% 8.09% 7.76% 7.91% 9.14% 9.05%
0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
13.05% 13.78% 15.12% 17.29% 17.94% 17.39% 17.34% 16.98% 17.29% 17.09% 16.98% 17.65%
0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%
No. of Shareholders 1,02,9941,20,5061,38,0521,60,6861,78,3561,77,7921,85,7872,05,6392,26,4802,28,1232,20,5612,11,173

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls